Relation between coronavirus disease 2019 severity and short outcome in rheumatic disease Patients
Background Three years ago, the coronavirus disease 2019 (COVID-19) was the most threatening issue that the world was forced to fight. The interrelationship between COVID-19 and autoimmunity is complex and bidirectional. There was world concern about the severity of COVID infection in rheumatic pati...
Main Authors: | Rasha M Hassan, Dalia A. El Sattar El Embaby, Sara F Samaan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Egyptian Journal of Chest Disease and Tuberculosis |
Subjects: | |
Online Access: | http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2023;volume=72;issue=2;spage=268;epage=276;aulast=Hassan |
Similar Items
-
Use of the rheumatic drug tocilizumab for treatment of SARS-CoV-2 patients
by: Bogna Grygiel-Górniak, et al.
Published: (2021-08-01) -
Incidence and inhospital outcomes of coronavirus disease 2019-associated pulmonary aspergillosis in the United States
by: Aditya Sharma, et al.
Published: (2024-01-01) -
Correlation of clinical, laboratory, ventilation, and outcome parameters in hospitalized Coronavirus Disease 2019-infected patients with computed tomography severity score
by: Mohammed A Ibrahim, et al.
Published: (2023-01-01) -
CT-Severity Analysis of Covid-19 Pneumonia in Rheumatic Musculoskeletal Diseases
by: Ali Murat Koc, et al.
Published: (2021-09-01) -
Combating coronavirus disease 2019 at home: evaluation of home treatment approach for patients diagnosed with coronavirus disease 2019 with moderate and severe symptoms in Egypt
by: Mohamed F Elbagalaty, et al.
Published: (2022-01-01)